#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chondrosarcoma Leber's congenital amaurosis Thermal burn Duchenne muscular dystrophy Choroidal dystrophy Leiomyosarcoma metastatic Gastrooesophageal cancer Neurotrophic keratopathy Malformation venous Acute on chronic liver failure Ovarian cancer Squamous cell carcinoma of head and neck KBG syndrome Arrhythmia Myxoid liposarcoma More trials…

    Learn about Rare Diseases

    Leiomyosarcoma metastatic – Life with Disease Familial amyotrophic lateral sclerosis – Basic Information Hepatoblastoma – Basic Information Marfan’s syndrome Primary hyperoxaluria – Diagnostics Cystic fibrosis Acute respiratory distress syndrome – Trials in Disease Myelodysplastic syndrome with excess blasts – Treatment Nephrotic syndrome – Diagnostics Basal cell naevus syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Daplusiran Plerixafor Alpelisib Pegipanermin Trametinib Zilucoplan Sodium Tebipenem Pivoxil Hydrobromide Gadobenate Dimeglumine DESMOPRESSIN ACETATE Taminadenant Medi0618 T89 Sugammadex FLUORIDE Triptorelin Oxygen Ph.eur. The-630 Cd7-Cart01 OBI-821 R-Azasetron Besilate More therapies…

    Learn about Your Condition

    Laryngeal cancer stage I Muscle spasticity Polyneuropathy Colorectal adenoma Pulmonary vascular disorder Andersen-Tawil syndrome Metastatic malignant melanoma Infantile apnoea Endocarditis enterococcal Obliterative bronchiolitis Uterine cancer Patent ductus arteriosus Hepatic neoplasm Acquired ATTR amyloidosis Hepatic angiosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Therapeutics

  • A study to evaluate the use of meropenem to reduce the risk of sepsis in patients with suspected infection in the emergency department

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Bacterial infection
    • Sepsis
    Investigated Drugs:
    • Meropenem Anhydrous
    • Sodium Chloride
    Greece

  • Study of the effect of empagliflozin on protein levels in the urine for patients with type 2 diabetes and kidney disease.

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Empagliflozin
    France

  • A study to evaluate the safety and effectiveness of oxaliplatin delivered directly to the liver for patients with colorectal cancer and liver metastasis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Oxaliplatin
    Belgium

  • Study of ustekinumab, adalimumab, and baricitinib for patients with folliculitis decalvans that is difficult to treat

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Adalimumab
    • Baricitinib
    • Ustekinumab
    France

  • Study comparing 7-day versus 14-day antifungal treatment for patients with uncomplicated candidemia using fluconazole, anidulafungin, or other medications

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Caspofungin
    • Anidulafungin
    • Fluconazole
    France

  • A study on ketamine maintenance treatment for patients with treatment-resistant major depression disorder

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Major depression
    • Depression
    Investigated Drugs:
    • Ketamine Hydrochloride
    Norway
Previous Page
1 … 13 14 15 16 17 … 24
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!